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Abstract 
Correlation Between Pluripotent Stem Cell Markers and microRNA 
Expression in Dental Pulp Stem Cells 
 
By 
 
Mark Whiting 
 
Dr. Karl Kingsley, Examination Committee Chair 
Associate Professor of Biomedical Sciences 
Director of Student Research 
University of Nevada, Las Vegas 
School of Dental Medicine 
 
 
In human development there are many factors that cause our cells to form certain organs 
and systems with specific functions. These cells original start as stem cells before biological 
processes take over and cause differentiation into different cell lines.  Since these 
undifferentiated stem cells have been discovered, many studies have been done to try and find 
the exact mechanism that causes a cell to change into another specific cell.  Due to the multiple 
sources that stem cells can be harvest from the human body, this knowledge of how 
differentiation works could lead to breakthroughs in regenerative medicine. 
 Traditional biomarkers have been the focus of much research in identifying 
characteristics of stem cells. Biomarkers include Oct-4, Sox-2, NANOG, and Nestin.  The 
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aforementioned biomarkers have been shown to identify stem cells that have pluripotent 
properties with potential to differentiate.  
 MicroRNA (miRNA) are small nucleotide chains that have been the topic of 
research in recent years. These chains have been shown to be involved in affecting gene 
expression and silencing.  Thi
 
 The data for the following two studies provide evidence of the existence of certain 
miRNAs in a unique source of stem cells, specifically dental pulp stem cells (DPSC). The 
miRNA molecules investigated in these DPSCs include miR-16, miR-27, miR-124, miR-135, 
and miR-218. Evidence suggests the presence of specific miRNA in certain DPSC lines which 
include miR-16, miR-27, miR-124 and miR-218. With differential expression of miR-27, miR-
124 and miR-218 in our different DPSC lines, evidence suggest these miRNA may impact the 
cells potential for differentiation. 
 Furthermore, these miRNA molecules were cross-referenced with the expression 
of certain characteristics of these DPSC line. Characteristics include the presence of biomarkers 
Oct-4, Sox-2, NANOG and Nestin. In addition, we also looked at their relation to the DPSC lines 
viability and proliferation rates. Our results have shown that biomarkers Oct-4, Sox-2 and Nanog 
correlated more with total live cell count whereas miRNAs miR-27, miR218, miR-124 and miR-
16 were more closely related to cellular viability. Further research will be needed to more fully 
understand the relationship.  
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Chapter 1: Introduction 
Background and Significance 
 Stem cells have been the topic of much research in recent years due to their unique 
biological properties. Their stemness and pluripotent properties make them ideal tools in 
regenerative medicine and scientists have found many sources of stem cells in the human 
body.[1-3]  These sources include bone marrow, adipose tissue, periodontal tissue, heart tissue, 
peripheral blood and dental pulp cells.[4-8]  Dental pulp stem cells (DPSC) are unique in their 
ease of access compared to other stem cells and are the focus of our research. 
 Past research has been done focusing on the analysis of several key biomarkers as they 
relate to pluripotency such as Oct-4, Sox-2, and NANOG.[9-10] Although the study of these 
biomarkers has helped to better understand DPSC, there is still much that is unknown. We hoped 
to expand on our knowledge through the evaluation of microRNA as they pertain to DPSC. 
 MicroRNA molecules are small non-coding RNA molecules involved in repression and 
activation of transcriptional factors in stem cells.[11-12] MicroRNA molecules have been shown 
to be involved in cellular differentiation and in altering expression of certain cell lineage. Their 
inclusion in this study will hopefully help to better understand DPSC and their usefulness in 
regenerative medicine. 
Research Question 
Based upon the paucity of evidence regarding miRNA expression among DPSC, the primary 
goal for this study was to evaluate expression of several key miRNAs, including miR-16, miR-
27, miR-124, and miR218 
 
1. Can microRNAs be detected in RNA isolated from primary DPSC explant? 
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H0: No microRNA will be detectable from RNA isolated from DPSC explant. 
HA: MicroRNA will be detectable from RNA isolated from DPSC explants. 
2.  Is there a correlation between microRNA expression and DPSC biomarkers or cellular 
phenotypes? 
H0: There are no correlations between microRNA expression and DPSC biomarkers or 
cellular phenotypes. 
HA: There are correlations between microRNA expression and DPSC biomarkers or cellular 
phenotypes. 
 
Approval  
This project was reviewed and approved by the Institutional Review Board(IRB) office 
and the Protection of Human Subject (OPRS) under protocol OPRS#763012-
analysis of dental pulp stem cells (DPCS) from at the University of Nevada, Las Vegas  School 
using protocol OPRS#0907- ion of Non-   
 
  
  3 
References 
1. Hollands P, Aboyeji D, Orcharton M. Dental pulp stem cells in regenerative medicine. Br 
Dent J. 2018 May 4. doi: 10.1038/sj.bdj.2018.348. [Epub ahead of print] PMID: 
29725075 
2. Ledesma-Martínez E, Mendoza-Núñez VM, Santiago-Osorio E. Mesenchymal Stem Cells 
Derived from Dental Pulp: A Review. Stem Cells Int. 2016;2016:4709572. doi: 
10.1155/2016/4709572. Epub 2015 Dec 8. Review. PMID:26779263 
3. Kabir R, Gupta M, Aggarwal A, Sharma D, Sarin A, Kola MZ. Imperative role of dental pulp 
stem cells in regenerative therapies: a systematic review. Niger J Surg. 2014 Jan;20(1):1-
8. doi: 10.4103/1117-6806.127092. Review. PMID: 24665194 
4. Bara JJ, Richards RG, Alini M, Stoddart MJ. Concise review: Bone marrow-derived 
mesenchymal stem cells change phenotype following in vitro culture: implications for 
basic research and the clinic. Stem Cells. 2014 Jul;32(7):1713-23. doi: 
10.1002/stem.1649. Review. PubMed PMID: 24449458 
5. Chou SH, Lin SZ, Kuo WW, Pai P, Lin JY, Lai CH, Kuo CH, Lin KH, Tsai FJ, Huang 
CY. Mesenchymal stem cell insights: prospects in cardiovascular therapy. Cell 
Transplant. 2014;23(4-5):513-29. doi: 10.3727/096368914X678436. Review. PubMed 
PMID: 24816448 
6. Leeman KT, Fillmore CM, Kim CF. Lung stem and progenitor cells in tissue homeostasis and 
disease. Curr Top Dev Biol. 2014;107:207-233. doi: 10.1016/B978-0-12-416022-
4.00008-1. Review. PubMed PMID: 24439808; PubMed Central PMCID: PMC4038302 
  4 
7. Lim MH, Ong WK, Sugii S. The current landscape of adipose-derived stem cells in clinical 
applications. Expert Rev Mol Med. 2014 May 7;16:e8. doi: 10.1017/erm.2014.8. Review. 
PubMed PMID: 24807467 
8. La Noce M, Paino F, Spina A, Naddeo P, Montella R, Desiderio V, De Rosa A, Papaccio G, 
Tirino V, Laino L. Dental pulp stem cells: state of the art and suggestions for a true 
translation of research into therapy. J Dent. 2014 Jul;42(7):761-8. doi: 
10.1016/j.jdent.2014.02.018. Epub 2014 Feb 28. Review. PubMed PMID: 24589847 
9. Liu L, Wei X, Ling J, Wu L, Xiao Y. Expression pattern of Oct-4, Sox2, and c-Myc in the 
primary culture of human dental pulp derived cells. J Endod. 2011 Apr;37(4):466-72. doi: 
10.1016/j.joen.2010.12.012. Epub 2011 Feb 25. PMID: 21419292 
10. Kaukua N, Chen M, Guarnieri P, Dahl M, Lim ML, Yucel-Lindberg T, Sundström E, 
Adameyko I, Mao JJ, Fried K. Molecular differences between stromal cell populations 
from deciduous and permanent human teeth. Stem Cell Res Ther. 2015 Apr 18;6:59. doi: 
10.1186/s13287-015-0056-7. PMID: 25927523 
11. Amin ND, Bai G, Klug JR, Bonanomi D, Pankratz MT, Gifford WD, Hinckley CA, Sternfeld 
MJ, Driscoll SP, Dominguez B, Lee KF, Jin X, Pfaff SL. Loss of motoneuron-specific 
microRNA-218 causes systemic neuromuscular failure. Science. 2015 Dec 
18;350(6267):1525-9. doi: 10.1126/science.aad2509. PubMed PMID: 26680198; 
PubMed Central PMCID: PMC4913787 
12. Wang T, Xu Z. miR-27 promotes osteoblast differentiation by modulating Wnt 
signaling. Biochem Biophys Res Commun. 2010 Nov 12;402(2):186-9. doi: 
10.1016/j.bbrc.2010.08.031. Epub 2010 Aug 12. PubMed PMID: 20708603 
  
  5 
Chapter 2 
Expression of microRNA miR-27, miR-124 and miR-218 Among Dental Pulp Stem Cell (DPSC) 
Isolates 
 
Current Research in Dentistry , An Int. Journal, and is 
presented in the style of that Journal. The complete Citation is: 
 
Whiting M, Kingsley K. Expression of microRNA miR-27, miR-124 and miR-218 Among 
Dental Pulp Stem Cell (DPSC) Isolates. Current Research in Dentistry vol 9: 12-18, 2018; 
DOI:10.3844/crdsp.2018.12.18. 
 
Role of Authors: 
This work was carried out in collaboration between all authors. Author Mark Whiting was 
responsible for sample preparation, RNA isolation and experimental protocol. Authors Dr. Karl 
Kingsley and Dr. Mark Whiting were responsible for project design, funding and manuscript 
preparation. All authors read and approved the final manuscript. 
 
Abstract 
Dental Pulp Stem Cells (DPSCs) are non-embryonic, mesenchymal stem cells that may 
have significant potential for therapeutic and regenerative biomedical applications. MicroRNAs 
are small non-coding RNA molecules that can act as transcriptional activators and repressors in 
many types of mesenchymal stem cells. To date, few studies have evaluated the expression or 
activity of microRNAs among dental pulp stem cells. Using eight previously isolated and 
characterized DPSC lines, RNA was extracted and examined using PCR to determine expression 
of several key miRNAs, including miR-16, miR-27, miR-124, miR-135, miR-143 and miR-218. 
These data demonstrated that at least four of these microRNAs are active among some of these 
DPSC isolates, including miR-16, miR-27, miR-124 and miR-218. Although the transcriptional 
targets of these miRNAs are not yet known, it is evident that the differential expression of some 
of these miRNAs (miR-27, miR-124, miR-218) may correlate (or even contribute) to 
differentiation status of these isolates. More research will be needed to determine the precise 
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function and targets of these microRNAs to determine their effects on DPSC differentiation, which 
may foster biotechnology applications for DPSC bioengineering applications. 
 
Key words: Dental pulp stem cell (DPSC), microRNA, cellular differentiation, 
bioengineering 
 
Abbreviations: dental pulp stem cells (DPSC), mesenchymal stem cells (MSC), Institutional 
Review Board (IRB), Office for the Protection of Human Subjects (OPRS), University of 
Nevada, Las Vegas  School of Dental Medicine (UNLV-SDM), microRNAs (miR),  cemento-
enamel junction (CEJ), total RNA isolation reagent (TRIR), Polymerase chain reaction 
(PCR), doubling time (DT), rapid doubling times (rDT), slow doubling times (sDT), 
intermediate doubling times (iDT), phosphate buffed saline (PBS)  
Introduction 
Dental Pulp Stem Cells (DPSCs) are non-embryonic, mesenchymal stem cells that may have 
significant potential for therapeutic and regenerative biomedical applications (Hollands et al., 2018; 
Ledesma-Martínez et al., 2016; Kabir et al., 2014). Many of these research studies regarding these 
potential treatments have focused on dental and oral tissues (Hernández-Monjaraz et al., 2018; 
Aurrekoetxea et al., 2015; Duncan et al., 2016). However, other research has suggested that DPSC may 
be useful to biomedical engineering and tissue regeneration efforts for tissues outside of the oral cavity or 
head and neck tissues (Daltoé et al., 2014; Collart-Dutilleul et al., 2015;   Mead et al., 2017; Victor and 
Reiter, 2017).  
Although much has been discovered regarding the regenerative potential of DPSC, many facets of 
DPSC isolation and differentiation have yet to be elucidated (Zainuri et al., 2018; Bakopoulou et al., 
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2017; Bakkar et al., 2017). For example, some evidence may suggest the method of isolation may 
influence the stem cell properties and alter the differentiation potential of DPSC isolates (Hilkens et al., 
2013; Karamzadeh et al., 2012; Rodríguez-Lozano et al., 2012). However, due to the recent discovery of 
DPSCs and their regenerative potential, much remains to be discovered regarding the mechanisms that 
may control differentiation, such as epigenetic regulation-which have been more extensively studied in 
other types of Mesenchymal Stem Cells (MSC) (Saidi et al., 2017; Ozkul and Galderisi, 2016; Deng et 
al., 2015).  
MicroRNAs are small non-coding RNA molecules that can act as transcriptional activators and 
repressors in many types of mesenchymal stem cells (Katsuda and Ochiya, 2015; Utikal et al., 2015; 
Huang et al., 2016; Martin et al., 2016) Some microRNAs (miR), such as miR-21 and miR-16 appear to 
be significant biomarkers and modulators of MSC potential and differentiation (Sekar et al., 2015; Clark 
et al., 2014; Fakhry et al., 2013). To date, few studies have evaluated the expression or activity of 
microRNAs among dental pulp stem cells     (Tu et al., 2018; Sun et al., 2017; Li et al., 2015). 
Based upon the paucity of evidence regarding miRNA expression among DPSC, the primary goal 
of this study was to evaluate expression of several key miRNAs, including miR-16, miR-27, miR-124, 
miR-135, miR-143 and miR-218. 
Methodology 
 Project approval 
The review and approval for this project was facilitated by the Office for the Protection of 
Research Subjects (OPRS) and Institutional Review Board (IRB) OPRS#763012-
analysis of Dental Pulp Stem Cells (DPSC) from the University of Nevada Las Vegas (UNLV) School of 
the DPSC samples was approved by the IRB and OPRS under protocol OPRS#0907-
Non-  
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In brief, adult patients that were scheduled for an extraction in the clinic prior to 
Orthodontic treatment (mainly for spacing issues) were asked to provide Informed Consent in 
order to participate. Any patients having teeth extracted due to other reasons, which included 
injury (fracture) or compromised dental pulp, pulp infection or disease, were excluded from 
participation  
 
 DPSC Isolation 
The original isolation of the dental pulp from the pulp chamber following extraction involved 
cross sectioning of the extracted tooth (pre-molar or third molar) at the Cemento-Enamel Junction (CEJ), 
following by extraction of the dental pulp with an endodontic broach, that was subsequently placed into a 
sterile microcentrifuge tube containing Phosphate Buffered Saline (PBS) for transfer to the biomedical 
laboratory (Alleman et al., 2013; Hung et al., 2013).  
In brief, each DPSC isolate was allowed to grow for ten passages using the direct 
outgrowth method and the rate of growth or Doubling Time (DT) was evaluated and assessed as 
the interval between 1:4 pass aging and achieving confluence. The analysis of DPSC isolate 
growth allowed for the identification of three distinct rates of DPSC growth, rapid Doubling 
Times (rDT) less than three days, slow Doubling Times (sDT) of greater than one week (8-10 
days) and a smaller subset with intermediate Doubling Times (iDT) (Young and Kingsley, 2015; 
Tomlin et al., 2016). Each DPSC isolate was then cryopreserved at -80C for future analysis and 
experimentation.  
 
RNA isolation 
For the current project, DPSC isolates were removed from storage and RNA was 
extracted from an aliquot of each DPSC isolate using 1.0 107 cells using the total RNA isolation 
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reagent (TRIR) from Molecular Research Center, Inc. (Cincinnati, OH) using the protocol 
recommended by the manufacturer. The quantification of RNA concentration and purity was 
then assessed using spectrophotometric analysis of each sample at 260 and 280 nm. The ratio of 
A260:A280 measurements provide a measurement of RNA purity (acceptable range between 
1.7-2.0) and a general estimate of quantity. 
All isolates with sufficient quality (A260:A280 > 1.7) and quantity (> 1 n/guL) were 
processed and screened for microRNA biomarker expression as previously described (Petersen 
and Kingsley, 2016; Brennan et al., 2018). Mesenchymal Stem Cell (MSC) biomarkers used in 
this screening included several previously validatedmiR-27, miR-124, miR-135, miR-143 and 
miR-218, as well as the internal validation control, miR-16, as follows: 
miR- -TAGCAGCACGTAAATATTGGCG- -16 
-TGCGTGTCGTGGAGTC- PCR): 54.3°C 
 
miR- -ATATGAGAAAAGAGCTTCCCTGTG- -27 
-  
Optimal Tm (PCR): 56.2°C 
 
miR-124- -ATGAATTCTCGCCAGCTTTTTCTT- -124 
reverse: 5 -ATGAATTCATTTGCATCTGCACAAACCC-  
Optimal Tm (PCR): 54.4°C 
 
miR- -CGATATGGCTTTTTATTCCTA -  
miR- -GAGCAGGGTCCGAGGT -  
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Optimal Tm (PCR): 49.8°C 
miR- -AGTGCGTGTCGTGGAGTC-  
miR- -GCCTGAGATGAAGCACTGT-  
Optimal Tm (PCR): 54.6°C 
 
miR- -TCG GGC TTG TGC TTG ATC T-  
miR- -GTG CAG GGT CCG AGT G-  
Optimal Tm (PCR): 61°C 
 
Results 
To screen for the expression of specific non-coding RNA, total RNA was isolated from 
each DPSC and quantified to determine any differences in total RNA expression among the 
DPSC isolates (Table 1). These data revealed that total RNA obtained from DPSC isolates with 
rapid, slow and intermediate doubling times (rDT, iDT, sDT) were similar, p = 0.9646. More 
specifically, the average total RNA isolated from each type of DPSC isolate was not significantly 
different  although two isolates (dpsc-5653 rDT, dpsc-11418 sDT) had total RNA extraction 
values that were slightly lower than the majority of DPSC isolates. 
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Table 1. RNA isolation and concentration from DPSC isolate 
DPSC isolate RNA quantification Statistical analysis 
rDT 912.8 ng/uL +/- 22.5 =0.072 
iDT 929.8 ng/uL +/- 5.9 d.f.=2 
sDT 913.5 ng/uL +/- 36.1 p=0.9646 
   
dpsc-3882 (rDT) 921.1 ng/uL  
dpsc-5653 (rDT) 887.3 ng/uL  
dpsc-7089 (rDT) 930.1 ng/uL  
   
dpsc-8124 (iDT) 925.6 ng/uL  
dpsc-17322 (iDT) 933.9 ng/uL  
   
dpsc-11418 (sDT) 879.4 ng/uL  
dpsc-11750 (sDT) 910.0 ng/uL  
dpsc-11836 (sDT) 951.2 ng/uL  
   
 Range: 879.4  951.2 ng/uL 
Average: 917.3 ng/uL 
 
 
Following the successful isolation of RNA from all DPSC isolates with sufficient 
concentration for analysis, an assessment of the RNA quality was performed to determine the 
suitability of this RNA for subsequent PCR screening (Table 2). These data revealed the RNA 
purity (measured by the ratio of absorbance readings at 260 and 280 nm) was sufficient for PCR 
screening and analysis (A260:A280>1.65), with no significant differences observed between 
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rDT, iDT and sDT averages, p = 0.4849. Only one DPSC isolate (dpsc-3882 rDT) was found to 
be slightly below the commonly accepted average purity standard (A260:A280 = 1.54). 
Table 2. RNA purity from DPSC isolates 
DPSC isolate RNA purity (A260:A280) Statistical analysis 
rDT 1.67 =1.447 
iDT 1.77 d.f.=2 
sDT 1.84 p=0.4849 
   
dpsc-3882 (rDT) 1.54  
dpsc-5653 (rDT) 1.77  
dpsc-7089 (rDT) 1.72  
   
dpsc-8124 (iDT) 1.65  
dpsc-17322 (iDT) 1.89  
   
dpsc-11418 (sDT) 1.91  
dpsc-11750 (sDT) 1.83  
dpsc-11836 (sDT) 1.79  
   
 Range: 1.54-1.91 
Average: 1.76 
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Following the characterization of RNA obtained from each DPSC isolate, RT-PCR was 
utilized to screen the RNA for expression of non-coding microRNA (Fig. 1). These data revealed 
that all DPSC isolates expressed miR-16 (positive control), as expected. Screening for the 
additional microRNAs revealed differential expression of miR-27, miR-124 and miR-218. More 
specifically, miR-27 expression was observed among the rDT but not the iDT or SDTDPSC 
isolates. In contrast, miR-124 expression was observed only among the sDT but not the rDT or 
iDT DPSC isolates. However, miR-218 was expressed among all the sDT and one of the rDT 
DPSC isolates but not among the iDT isolates. No expression of miR-135 or miR-143 was 
observed among any DPSC isolate screened.  
  14 
 
Fig1. Expression of miRNA among DPSC isolates. Screening for miRNA among eight DPSC 
isolates revealed expression of miR-16 (positive control) among all DPSC isolates and 
differential expression of miR-27, miR-124 and miR-218. No expression was observed for miR-
135 or miR-143 (data not shown) 
Discussion 
Based upon the paucity of evidence regarding miRNA expression among DPSC, the 
primary goal of this study was to evaluate expression of several key miRNAs, including miR-16, 
miR-27, miR-124, miR-135, miR-143 and miR-218. The results of this pilot study have revealed 
that RNA could be successfully isolated and screened for microRNA expression among all the 
DPSC isolates. Furthermore, although the expression of the positive control microRNA (miR-16) 
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was observed among all DPSC isolates, differential or lack of expression was observed among 
each of the remaining microRNAs (Yu et al., 2013; Eguchi et al., 2013). 
These results are significant as the evidence for microRNA expression among DPSC 
isolates is in the very early stages of exploration and few studies to date have evaluated this 
phenomenon (Tu et al., 2018;     Sun et al., 2017; Li et al., 2015). This study screened for miR-
143 and miR-135 expression, which was demonstrated to function in the pathway for myogenic 
differentiation of DPSC (Li et al., 2015), although virtually no information is currently available 
about the normal function and expression of these microRNA among non-differentiated DPSC.  
The results of this study greatly expand the range of microRNA expression profiles 
among DPSC to include several key regulators of MSC activity, such as miR-218 which is 
known to regulate proliferation and stem cell activity through the TOB1 (transducer of ERBB2, 
1) pathway (Gao et al., 2016). In addition, the role of miR-124 which may function to modulate 
the Wnt/beta-catening pathway and MSC chemotaxis  although no study has yet confirmed the 
expression of miR-218 in DPSC (Yue et al., 2016; Laine et al., 2012). Finally, this study may be 
the first evidence of the expression of miR-27 among DPSC, which has been identified as a 
critical microRNA modulating the tolerogenic response of adipose-derived MSCs (Chen et al., 
2013).  
Despite the significance of these findings, some limitations must also be discussed. For 
example, this study represents a small number of individual DPSC isolates and may therefore not 
be representative of all DPSC isolates (Alleman et al., 2013; Hung et al., 2013). In addition, the 
differential expression of microRNAs in this study may be functionally related to other factors 
that have not yet been identified  although significant amounts of information and 
characterization regarding these DPSC has already been identified (Young and Kingsley, 2015; 
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Tomlin et al., 2016). Finally, financial and other temporal constraints limited the number of 
microRNAs that could be screened which may suggest additional microRNAs that mediate the 
expression of those newly identified from this study (miR-27, miR-124, miR-218) may be high 
priorities for future studies of these DPSC isolates.   
Conclusions 
Although the transcriptional targets of these miRNAs are not yet known, it is evident that 
the differential expression of some of these miRNAs (miR-27, miR-124, miR-218) may correlate 
(or even contribute) to differentiation status of these isolates. More research will be needed to 
determine the precise function and targets of these microRNAs to determine their effects on 
DPSC differentiation, which may foster biotechnology applications for DPSC bioengineering 
applications. 
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Chapter 3 
Pluripotent stem cell markers and microRNA expression may correlate with dental pulp stem cell 
viability and proliferation rates 
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Abstract 
Background: Recent evidence has demonstrated that dental pulp-derived stem cells 
(DPSC) may represent a source of pluripotent progenitors capable of differentiating into many 
cell and tissue types. Although microRNAs are known to modulate differentiation and function 
in human dental tissues, much of this research has focused selectively on tooth development. The 
primary objective of this study was to evaluate the expression of microRNA in dental pulp stem 
cell isolates to compare with classical biomarkers of cellular phenotypes and pluripotency 
Methods: Using eight previously isolated and characterized DPSC isolates, growth and 
viability were evaluated and RNA extracted for mRNA screening. DPSC biomarker and 
microRNA expression was analyzed for comparison with cellular phenotypes.  
Results: Evaluation of the growth and proliferation rates of each cell line resulted in 
categorization of DPSC isolates into rapid, intermediate and slow doubling times, which 
demonstrated higher viability among the most rapidly proliferating DPSCs. Analysis of DPSC 
biomarkers (Oct-4, Sox-2, NANOG) revealed an association with total live cell count, while 
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microRNA expression (miR-27, miR-218, miR-124, miR-16) appeared to be more closely 
associated with cellular viability.  
Conclusions: Although this study was limited to a small number of DPSC isolates, these 
results suggest a more thorough investigation and evaluation of biomarkers and microRNA 
expression may be necessary to elucidate the associations and complex interconnections with 
DPSC viability, proliferation, differentiation and pluripotency.  
 
Key words: dental pulp stem cells (DPSC), microRNA, biomarkers, pluripotency 
 
List of abbreviations: dental pulp stem cells (DPSC), mesenchymal stem cell (MSC), the 
Institutional Review Board (IRB), Office for the Protection of Research Subjects (OPRS), 
Doubling time (DT), rapid doubling time (rDT), intermediate doubling time (iDT), slow 
doubling time (sDT) 
Background 
Recent evidence has demonstrated that dental pulp-derived stem cells (DPSC) may 
represent a source of pluripotent progenitors capable of differentiating into many cell and tissue 
types [1,2] some of which may have therapeutic potential. Several key markers of pluripotency 
in DPSC have been identified, including the transcription factors Oct-4, Sox-2 and NANOG 
[3,4]. Although many studies have evaluated the functional effects of these transcriptional 
activators and repressors, many factors that contribute to maintaining pluripotency among DPSC 
remain undiscovered [5-7].  
For example, recent evidence now suggests that mesenchymal stem cell (MSC) 
differentiation may be regulated not only by classical stem cell-associated transcription factors 
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(Sox-2, Oct-4, NANOG)  but also via transcriptional modulation by long, non-coding RNA 
known as microRNA [8,9]. In fact, there is some evidence that specific microRNAs may also be 
useful as biomarkers to identify and distinguish stem cells with differing therapeutic potential 
[10-12]. Although an extensive body of evidence has accumulated regarding the role of 
microRNAs and MSC, few (if any) studies have focused more specifically on the role of DPSC 
[13]. 
Although microRNAs are known to modulate differentiation and function in human 
dental tissues, much of this research has focused selectively on tooth development [14-16]. 
Developmental biology requires a thorough understanding of these mechanisms; however, recent 
studies now suggest that DPSC may also be useful in bioengineering and therapeutic applications 
for regenerative medicine [17-18]. Promising areas of interest include bone and neural tissue 
engineering using DPSC,  although much remains to be discovered regarding the mechanisms 
that control these processes [19,20].  
Research from our group has evaluated classical biomarkers and other factors that may 
influence the therapeutic potential of primary explants and DPSC isolates [21,22]. The most 
recent study from this group may have also identified a limited number of microRNAs that may 
influence DPSC pluripotency and differentiation, including miR-27, miR-124 and miR-218 [23].  
Many other studies have examined the role of these microRNAs in MSC, although only a single, 
recent study has examined miR-218 in DPSC and none have evaluated the concomitant presence 
(or absence) of traditional biomarkers [24-26]. 
In order to advance the  evidence in this area, the primary objective of this study was to 
evaluate the expression of microRNA in dental pulp stem cell isolates to compare with classical 
biomarkers of cellular phenotypes and pluripotency  
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Material and Methods 
Human subjects 
This project was reviewed and approved by the Institutional Review Board (IRB) and 
Office for the Protection of Research Subjects (OPRS) under protocol OPRS#763012-1 
Vegas  
originally collected using protocol OPRS#0907- of Non-Embryonic Stem Cells 
 
In brief, patients scheduled for extraction of third molars for Orthodontic treatment 
(primarily indicated for spacing and crowding), were asked to participate. Informed Consent (and 
Pediatric Assent) were provided. Exclusion criteria included refusal to participate, provide 
Informed Consent/Assent, or compromised dental pulp due to injury, fracture, infection or 
disease.  
Following cross sectioning of the extracted tooth at the cemento-enamel junction, DPSC 
were extracted from the pulp chamber using an endodontic broach and transferred to the 
laboratory for culture and analysis, as previously described [27,28]. Growth for a minimum of 
ten (10) passages were allowed for each DPSC isolate, as part of the direct outgrowth method 
[29,30]. 
 
Growth and Proliferation 
Doubling time (DT) was established for each DPSC isolate using the growth rate 
measured between 1:4 passaging and achieving confluence. These data were used to characterize 
three distinct categories of DPSC growth, rapid doubling time (rDT) of two to three days, 
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intermediate doubling time (iDT) five to seven days, and slow doubling time (sDT) of ten to 
fourteen days [21,22].  
 
Cellular viability and Photo microscopy  
Analysis of cellular viability was performed using the Trypan Blue exclusion method and 
the BioRad TC20 automated cell counter, using the manufacturer recommended protocol. These 
data provided both live and total cell count, allowing for the calculation of the percentage of 
viable cells in each sample, as previously described [27,28,31]. Digital images of DPSC isolates 
were captured using the Lionheart LX Automated Microscope and 20X objective lens. 
 
Statistical analysis 
Rates of proliferation and cellular viability were measured and these descriptive statistics 
-tailed t-test. Statistical significance was set 
using an alpha level ( ) =0.05.  
 
RNA isolation and Polymerase Chain Reaction (PCR) 
RNA was extracted from each DPSC isolate using Total RNA isolation reagent (TRIR) 
from Molecular Research Center and the manufacturer recommended protocol [23,27]. RNA was 
analyzed to determine purity using spectrophotometric absorbance readings at 260 and 280 nm 
(A260:A280 ratio). All samples were required to meet the standard A260:A280 > 1.65.  
Screening for mRNA expression was facilitated using the ABgene Reverse-iT One-Step 
RT-PCR kit and protocol. The basic specifications were an initial reverse transcription at 47C for 
30 minutes and 30 cycles of the following: Denaturation 95C, annealing 30 seconds at selected 
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primer temperature (see below), Final extension 60C for 60 seconds. Results were obtained using 
gel electrophoresis and visualized using ethidium bromide with a Kodak Gel Logic 100 Imaging 
System. Primers were synthesized from Eurofins MWG Operon, as follows: 
 
DPSC biomarker primers:  
 
Oct- -TGGAGAAGGAGAAGCTGGAGCAAAA-  
-GGCAGATGGTCGTTTGGCTGAATA-  
Optimal Tm: 71C 
-ATGGGCTCTGTGGTCAAGTC-  
-CCCTCCCAATTCCCTTGTAT-  
Optimal Tm: 65C 
-GCTGAGATGCCTCACACGGAG-  
NANO -TCTGTTTCTTGACTGGGACCTTGTC-  
Optimal Tm: 70C 
-CGTTGGAACAGAGGTTGGAG-  
-TCCTGAAAGCTGAGGGAAG-  
Optimal Tm: 65C 
 
microRNA screening primers: 
 
miR- -ATATGAGAAAAGAGCTTCCCTGTG-  
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miR- -CAAGGCCAGAGGAGGTGAG-  
Optimal Tm: 65C 
miR- -TCGGGCTTGTGCTTGATCT-  
miR- -GTGCAGGGTCCGAGTG-  
Optimal Tm: 67C 
miR-124- -ATGAATTCTCGCCAGCTTTTTCTT-  
miR- -ATGAATTCATTTGCATCTGCACAAACCC-  
Optimal Tm: 66C 
miR- -TAGCAGCACGTAAATATTGGCG-  
miR- -TGCGTGTCGTGGAGTC-  
Optimal Tm: 66C 
Results 
Evaluation of the growth and proliferation rates of each DPSC isolate resulted in 
categorization of DPSC isolates into rapid, intermediate and slow doubling times (Table 1). The 
average doubling time (DT) for the rapid DPSC was 2.2 days, which was significantly less than 
the average doubling time for the intermediate (6.25 days) and slow DPSC isolates (12.1 days), 
p=0.0241.  
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Table 1. Analysis of DPSC growth rates. 
DPSC isolate Doubling Time Categorization
dpsc-3882 2.6 days rDT 
dpsc-5653 2.1 days rDT 
dpsc-7089 1.9 days rDT 
 rDT average: 2.2 days 
range: 1.9  2.6 days 
 
dpsc 8124 5.9 days iDT 
dpsc-17322 6.6 days iDT 
 iDT average: 6.25 days 
range: 5.9  6.6 days 
 
dpsc-11418 10.2 days sDT 
dpsc-11750 13.1 days sDT 
dpsc-11836 12.9 days sDT 
 sDT average: 12.1 days 
range: 10.2  13.1 days 
 
 
Cellular viability was then measured for each DPSC isolate to determine if any 
correlations could be found with growth rates and doubling time (Table 2). In brief, the cellular 
viability for the rDT DPSC isolates averaged 56%, ranging between 52% - 59%. The average 
was considerable higher than those observed among the iDT DPSC isolates (37%; range 35% - 
39%) or sDT DPSC isolates 31%; range 29-34%), p=0.311. 
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Table 2. Trypan Blue exclusion assay test for DPSC viability.  
DPSC isolate Cellular viability Categorization 
dpsc-3882 1.62 x 105 cells/mL TC 
0.84 x 105 cells/mL LC 
Viable: 52% 
 
rDT 
(2.6 days) 
dpsc-5653 1.90 x 105 cells/mL TC 
1.12 x 105 cells/mL LC 
Viable: 59% 
 
rDT 
(2.1 days) 
dpsc-7089 3.35 x 105 cells/mL TC 
1.90 x 105 cells/mL LC 
Viable: 57% 
 
rDT 
(1.9 days) 
rDT  Ave: 2.29 x 105 cells/mL TC 
Ave: 1.29 x 105 cells/mL LC 
Average viability: 56% 
 
dpsc 8124 3.68 x 105 cells/mL TC 
1.45 x 105 cells/mL LC 
Viable: 39% 
 
iDT 
(5.9 days) 
dpsc-17322 2.90 x 105 cells/mL TC 
1.00 x 105 cells/mL LC 
Viable: 35% 
 
iDT 
(6.6 days) 
iDT Ave: 3.29 x 105 cells/mL TC 
Ave: 1.23 x 105 cells/mL LC 
Average viability: 37% 
 
dpsc-11418 3.24 x 105 cells/mL TC 
0.948 x 105 cells/mL LC 
Viable: 29% 
 
sDT 
(10.2 days) 
dpsc-11750 3.24 x 105 cells/mL TC 
1.00 x 105 cells/mL LC 
Viable: 31% 
 
sDT 
(13.1 days) 
dpsc-11836 1.62 x 105 cells/mL TC 
0.558 x 105 cells/mL LC 
Viable: 34% 
 
sDT  
(12.9 days) 
sDT Ave: 2.70 x 105 cells/mL TC 
Ave: 0.835 x 105 cells/mL LC 
Average viability: 31% 
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To more closely evaluate cellular phenotypes and morphology, as well as to evaluate the 
presence of both viable and non-viable cells, digital micrographs were obtained from each DPSC 
isolate (Figure 1). Briefly, these data demonstrated multiple, non-adherent DPSC cells with 
fewer cells displaying signs of apoptosis (intense blebbing) among the rDT isolates (Fig. 1A.  
Fig. 1C). Higher proportions of these non-viable cells were observed among the iDT (Fig. 1D. 
Fig. 1H) and sDT isolates (Fig. 1. E  Fig. 1G.)  
 
Figure 1. DIC digital photomicrographs of freshly dispersed and cultured dental pulp stem cells 
-C) rapidly dividing (rDT) DPSC, (E-G) slowly dividing (sDT) DPSC, D+H 
intermediately dividing DPSC. Arrows showing intense cellular blebbing (apoptosis), scale bar = 
100 µm.  
To evaluate the association between growth and viability, DPSC biomarkers (Oct-4, Sox-
2, NANOG, Nestin) and microRNAs (miR-27, miR-218, miR-124, miR-16) were evaluated 
using RT-PCR for comparison with graphs of live and viable cells (Figure 2). More specifically, 
the total live counts from each cell line were plotted, which revealed the highest numbers among 
the rDT and iDT isolates (Fig. 2A). These data appear to correlate with the expression of 
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NANOG, Sox-2 and Oct-4 among the rDT and iDT isolates  although some variability in 
mRNA expression was observed (Fig. 2B).   
Although mRNA expression of at least two DPSC biomarkers was noted in all rDT and 
iDT isolates, the expression of all DPSC biomarkers was noted in only one DPSC isolate (dpsc-
7089), which was observed to have the highest overall live cell count and cell viability (Fig. 2B 
and Fig 2C). In addition, Oct-4 expression was not observed in either of the iDT isolates (dpsc-
8124, dpsc-17322). However, the expression of Sox-2 and NANOG was observed in all of the 
iDT isolates, unlike the variable expression observed among the rDT isolates. 
The highest overall viability was verified among the rDT isolates (dpsc-3882, dpsc-5653, 
dpsc-7089) with an average exceeding 50% (Fig. 2C). These data appear to correlate with the 
expression of miR-27, which was observed only among the rDT isolates (Fig. 2D). Expression of 
miR-124 was restricted to the sDT isolates, which appeared to have the lowest overall viability 
(approximately 30%), with variable expression observed with miR-218. It was noted that only 
miR-16 (control) expression was observed among the iDT isolates, with no expression of miR-
27, miR-124 or miR-218 observed.  
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Figure 2. Correlation of DPSC markers with microRNA expression. A) Graphed live cell counts 
from DPSC isolates demonstrated highest levels among rDT and iDT isolates. B) mRNA 
expression of DPSC biomarkers revealed Oct-4, Sox-2 and NANOG among rDT isolates 
(variable) and only Nestin expression among sDT isolates. C) Percentage of viable cells revealed 
higher percentages among rDT isolates compared with either iDT or sDT. D) MicroRNA 
expression of miR-27 was observed among rDT only, while miR-124 and miR-218 was observed 
mainly among the sDT isolates.  
Discussion 
The primary objective of this study was to evaluate the expression of microRNA in dental 
pulp stem cell isolates to compare with classical biomarkers of cellular phenotypes and 
pluripotency. Evaluation of the growth and proliferation rates of each cell line resulted in 
  36 
categorization of DPSC isolates into rapid, intermediate and slow doubling times, which 
demonstrated higher viability among the most rapidly proliferating DPSCs. Analysis of DPSC 
biomarkers (Oct-4, Sox-2, NANOG) revealed an association with total live cell count, while 
microRNA expression (miR-27, miR-218, miR-124, miR-16) appeared to be more closely 
associated with viability.  
These data appear to confirm recent studies that demonstrated proliferation and growth 
potential among DPSC isolates to be closely linked with expression of Sox-2 and other DPSC 
biomarkers, such as Oct-4 [32-34]. The results of this study also support previous findings from 
this group regarding the association between doubling time (growth) and these biomarkers 
[21,22,27]. In addition, these data also confirm one of the only studies to demonstrate an 
association between microRNA expression (miR-218) and DPSC viability and differentiation 
potential [35].  
Although only limited evidence regarding DPSC and microRNAs may be available, a 
growing body of evidence regarding microRNA expression and stem cell differentiation may 
suggest further research in this area is warranted [36,37]. For example, miR-124 may a key 
regulator of osteogenic, myogenic and neuronal differentiation in MSC  although this role has 
yet to be confirmed among DPSC [38-40]. miR-218 may also function in a similar capacity, as a 
key regulator of osteogenic differentiation in MSC [41].  
The role of miR-27 in differentiation of other MSC may be the most thoroughly 
examined of these microRNAs [24,25]. For example, miR-27 has been shown to promote 
osteoblast differentiation by directly modulating transcription of several key components of the 
beta-catenin/Wnt pathway [42]. miR-27 may also function to promote myeloblast differentiation 
through direct and indirect modulation of Runx1 transcription [43,44]. However, miR-27 has 
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also been shown to inhibit adipose differentiation and mitochondrial function via multiple 
pathways in other types of adipose-derived MSC [45-47].  
 
Conclusions 
Although this study was limited to a small number of DPSC isolates, these results suggest 
a more thorough investigation and evaluation of biomarkers and microRNA expression may be 
necessary to elucidate the associations and complex interconnections with DPSC viability, 
proliferation, differentiation and pluripotency. 
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Chapter 4: Summary and Conclusions. 
The goal of this project was to assess the presence of miRNA in DPSC lines. Due to the 
fact that certain miRNA have been shown to affect gene expression it is important to understand 
their role as it pertains to the pluripotent potential of DPSC and ultimately the differentiation of 
those specific cells. 
 Chapter 2 of this paper was a study of the presence of specific miRNA in our samples of 
DPSC.  Eight different DPSC lines were evaluated using PCR to determine that presence of mir-
R-16, miR-27, miR-124, and miR-218. Furthermore, it was determined there was differential 
expression of miR-27, miR-124, and miR-218. With further research these results may help 
further explain differentiation status of these cells. 
 Chapter 3 of this paper further evaluated the presence of miRNA presence in DPSC and 
its correlation with other characteristics.  We again used the same eight cell lines for DPSC 
samples and classified them into three categories based upon proliferation rates. These categories 
were rapid, intermediate, and slow dividing times with higher viability being more closely 
associated with rapid proliferation.  Furthermore, we analyzed the results as they correlated with 
the presence of the biomarkers Oct-4, Sox-2 and NANOG. Our conclusions were that the 
presence of biomarkers Oct-4, Sox-2 and NANOG were more closely connected with total live 
cell count whereas the presence of miRNAs miR-27, miR-124, and miR-218 were tied more 
closely to cellular viability.   
Conclusions from these 2 chapters led us to believe that there is a presence of certain 
miRNA in our DPSC samples. Because of this presence we can reject our null hypothesis and 
accept our alternative hypothesis for questions 1 of this paper.  In addition, our further analysis 
has shown correlation between miRNA expression and DPSC biomarkers with cellular viability 
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and total live count.  Due to these results we move to reject our null hypothesis and accept our 
alternative hypothesis in question 2 of this paper. 
 
1. Can microRNAs be detected in RNA isolated from primary DPSC explant? 
HA: MicroRNA will be detectable from RNA isolated from DPSC explants. 
2. Is there a correlation between microRNA expression and DPSC biomarkers or cellular 
phenotypes? 
HA: There are correlations between microRNA expression and DPSC biomarkers or cellular 
phenotypes. 
Limitations and Recommendations: 
As mentioned in previous chapters, one limitation for this study is the limited number of 
DPSC samples that were analyzed.  These limits were brought about by funding issues and 
viable cell lines available to use in this study since the original samples were collected in 
previous years.  I would recommend gathering more samples to analyze so that we could run 
statistical analysis to confirm the importance of certain miRNA found in DPSCs. 
 In addition, there are a limited number of studies from other research outlets to 
compare our results with.  Due to the vast number of different miRNA molecules that exist it is 
difficult narrow down which ones to include in the study. Further research needs to be done to 
determine the function of specific miRNA molecules before we look for their presence or 
absence in our DPSC samples. 
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